Immunoglobulin G1 (256-Tyrosine,258-Threonine,260-Glutamic Acid), Anti-(Neural Apoptosis-Regulated Proteinase 1) (Human-Mus Musculus Monoclonal Hrp00130 .Gamma.1-Chain), Disulfide With (3-Valine,5-Serine,49-Serine,66-Aspartic Acid) Human-Mus Musculus Monoclonal Hrp00130 .Kappa.-Chain, Dimer
Ischemic Stroke
Peking Union Medical College Hospitalmonoclonal_antibodyPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
197 Active assets in the Ischemic Stroke cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ticagrelor Sichuan Provincial People's Hospital | Phase 4 | BBB |
Cilostazol Stanford University | Phase 4 | BBB |
Compound Edaravone Nanfang Hospital, Southern Medical University | Phase 4 | BBB |
3-N-BUTYLPHTHALIDE Nanfang Hospital, Southern Medical University | Phase 4 | BBB |
Argatroban Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
Immunoglobulin G1 (256-Tyrosine,258-Threonine,260-Glutamic Acid), Anti-(Neural Apoptosis-Regulated Proteinase 1) (Human-Mus Musculus Monoclonal Hrp00130 .Gamma.1-Chain), Disulfide With (3-Valine,5-Serine,49-Serine,66-Aspartic Acid) Human-Mus Musculus Monoclonal Hrp00130 .Kappa.-Chain, Dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →